Cancer Neuroscience: How the Nervous System Influences Tumor Growth, Immunity and Cancer Therapy

 

Cancer Neuroscience: How the Nervous System Influences Tumor Growth, Immunity and Cancer Therapy

Introduction

Cancer research has traditionally focused on cancer cells, genetic mutations, immune responses, blood vessels, metabolism, and the surrounding tumor microenvironment. However, a rapidly emerging field is changing this perspective: cancer neuroscience.

Cancer neuroscience examines how the nervous system interacts with cancer cells, immune cells, stromal cells, and the tumor microenvironment. Increasing evidence suggests that nerves are not merely passive structures surrounding tumors. Instead, neural signals can influence tumor growth, invasion, metastasis, immune activity, treatment response, and potentially therapeutic resistance.

Recent research has shown that tumors can actively recruit and remodel nerves, while neural signals can alter the behavior of cancer and immune cells. This creates a dynamic, bidirectional relationship between tumors and the nervous system.

The field is particularly important because the nervous system can communicate through neurotransmitters, neuropeptides, synapse-like interactions, autonomic signaling, and neuroimmune pathways. These mechanisms may influence how tumors grow and how effectively the immune system responds to cancer.

A 2026 review in Signal Transduction and Targeted Therapy describes cancer neuroscience as an emerging area investigating neuronal activity, neurotransmitters, neuropeptides, hormones, and related signaling pathways that can support tumor progression, survival, and invasion.

At the same time, researchers are investigating whether neural pathways could become therapeutic targets. Approaches that modify neurotransmitter signaling, tumor innervation, or neuroimmune interactions may eventually complement established cancer treatments.

This article explores the growing field of cancer neuroscience, the relationship between nerves and tumors, the role of neuroimmune communication, tumor innervation, cancer therapy, treatment resistance, and the potential future of neural-targeted approaches in precision oncology.

 

What Is Cancer Neuroscience?

Cancer neuroscience is an interdisciplinary field that studies interactions between the nervous system and cancer.

It brings together concepts from:

• Oncology
• Neuroscience
• Immunology
• Molecular biology
• Tumor biology
• Neurobiology
• Pharmacology
• Precision medicine

Traditional cancer biology often treats the tumor microenvironment as a combination of cancer cells, immune cells, fibroblasts, blood vessels, extracellular matrix, and signaling molecules.

Cancer neuroscience adds another important component: the nervous system.

Researchers are increasingly investigating how peripheral nerves, sensory neurons, sympathetic and parasympathetic pathways, glial cells, neurotransmitters, neuropeptides, and central neural circuits interact with tumors.

This interaction can work in both directions.

The nervous system can influence cancer, while cancer can influence and remodel the nervous system.

Tumor cells may release factors that encourage nerve growth or recruitment. Newly recruited nerves can then provide signaling molecules that influence tumor behavior. At the same time, neural signals can alter immune-cell activity within the tumor microenvironment.

This creates what researchers increasingly describe as a neuro-tumor-immune axis.

 

How the Nervous System Interacts With Cancer

The nervous system communicates using several mechanisms that can potentially influence tumor biology.

These include:

• Neurotransmitters
• Neuropeptides
• Hormones
• Electrical activity
• Synapse-like signaling
• Autonomic nervous system pathways
• Neuroimmune signaling
• Growth factors
• Receptor-mediated signaling

Cancer cells can express receptors that respond to neurotransmitters and neuropeptides. Consequently, neural signals may directly alter cancer-cell proliferation, survival, migration, metabolism, and invasion.

Neural signaling can also indirectly affect tumors by modifying immune cells and stromal components within the tumor microenvironment.

For example, sympathetic signaling can influence immune-cell recruitment and function, while sensory neurons can release neuropeptides that affect local tumor and immune behavior. Recent reviews emphasize that these interactions may contribute to immune suppression and treatment resistance.

 

Tumor Innervation: When Cancer Recruits Nerves

One of the most fascinating discoveries in cancer neuroscience is that tumors can become innervated.

Tumor innervation refers to the presence and growth of nerve fibers within or around tumor tissue.

Cancer cells may release molecules that encourage nerve growth and recruitment. Research has implicated factors such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in tumor-associated neural remodeling.

Tumor-derived extracellular vesicles, including exosomes, may also participate in communication between cancer cells and neural or glial components.

The result can be a changing tumor microenvironment containing newly established neural connections.

This process is important because nerves may provide more than physical connections. They can release biological signals capable of influencing cancer cells and immune cells.

Recent research describes tumor-driven neural remodeling as a mechanism that may promote tumor progression, immune suppression, and dissemination.

 

Neural Signaling and Tumor Growth

Cancer cells require signals that support survival and proliferation.

Neural signals can contribute to these processes through receptor-mediated pathways.

Depending on the cancer type and neural pathway involved, neurotransmitters and neuropeptides may influence:

• Cell proliferation
• Survival signaling
• Migration
• Invasion
• Angiogenesis
• Metabolism
• Stem-like properties
• Therapy response

For example, research has demonstrated interactions between sensory neurons and cancer cells in which neuronal signaling can activate intracellular pathways that support tumor growth.

A 2026 review of cancer neuroscience highlights autonomic and sensory neural regulation as an important area of investigation for understanding tumor progression and therapeutic resistance.

Importantly, neural signaling does not necessarily have the same effect in every cancer. The biological consequences depend on the tumor type, neural subtype, receptor expression, tissue environment, and molecular context.

This complexity is one reason why cancer neuroscience is becoming closely connected with precision oncology.

 

The Sympathetic Nervous System and Cancer

The sympathetic nervous system is one of the major components being studied in cancer neuroscience.

Sympathetic nerves release neurotransmitters such as norepinephrine, which can interact with adrenergic receptors expressed by cancer cells and immune cells.

These interactions may affect:

• Tumor-cell signaling
• Immune-cell behavior
• Inflammation
• Tumor vascularization
• Metastasis
• Stress-associated biological pathways

The sympathetic nervous system can also influence immune responses.

Research indicates that adrenergic signaling may contribute to immunosuppressive environments by influencing immune-cell populations and functions.

This raises an important question for oncology research:

Could selective modulation of sympathetic signaling improve cancer treatment?

The answer is not yet established clinically across cancer types, but the question is increasingly being investigated.

 

Sensory Neurons and Cancer

Sensory neurons are traditionally associated with detecting pain and other environmental signals.

However, researchers now recognize that sensory neurons can participate in cancer biology.

Tumors may interact with sensory nerve fibers through growth factors, inflammatory signals, and neuropeptides.

Sensory neurons can release signaling molecules that affect nearby cancer and immune cells.

In some experimental models, tumor-associated sensory neurons have been associated with:

• Tumor growth
• Inflammation
• Immune modulation
• Cancer-associated pain
• Tumor survival
• Metastatic behavior

The relationship is complex because cancer pain and tumor progression are not identical biological processes. Nevertheless, the neural pathways involved in pain signaling can overlap with pathways affecting the tumor microenvironment.

Understanding this relationship may eventually help researchers develop strategies that address both cancer biology and cancer-associated neurological symptoms.

 

Neuro-Immune Interactions in Cancer

One of the most important areas within cancer neuroscience is the interaction between the nervous and immune systems.

The nervous and immune systems communicate continuously throughout the body.

In cancer, this communication can become dysregulated.

Neural signals can influence:

• T cells
• Natural killer cells
• Macrophages
• Myeloid-derived suppressor cells
• Dendritic cells
• Other immune populations

Recent research shows that sympathetic, parasympathetic, and sensory neural pathways can influence immune-cell recruitment, activation, and function within tumors.

This means the nervous system may indirectly influence whether the immune system recognizes and attacks cancer cells.

For example, neural signaling can contribute to an immunosuppressive tumor microenvironment by affecting immune-cell phenotypes and T-cell activity.

A 2026 review specifically highlights neural regulation of tumor immunity as a potential avenue for improving cancer immunotherapy.

 

How Neural Signals May Influence Cancer Immunotherapy

Cancer immunotherapy depends on effective immune recognition and activation.

Treatments such as immune checkpoint inhibitors work by helping the immune system mount stronger responses against cancer.

However, tumors can develop highly immunosuppressive environments that limit treatment effectiveness.

Neural signaling may be one component of this environment.

Research is investigating how tumor innervation can affect:

• T-cell activation
• T-cell exhaustion
• Natural killer cell activity
• Myeloid-cell function
• Immune-cell recruitment
• Cytokine signaling
• Immune checkpoint responses

Recent literature suggests that neural regulation may contribute to immune evasion and resistance to immune checkpoint inhibition.

This creates an interesting therapeutic possibility:

Could cancer treatments be combined with strategies that selectively modify tumor-associated neural signaling?

This remains an emerging research area rather than an established standard of care, but it could eventually become an important component of combination immunotherapy strategies.

 

The Tumor Microenvironment and Neural Regulation

The tumor microenvironment is not simply a physical space around cancer cells.

It is an active biological ecosystem.

It contains:

• Cancer cells
• Immune cells
• Fibroblasts
• Endothelial cells
• Extracellular matrix
• Blood vessels
• Signaling molecules
• Nerves
• Glial cells

Cancer neuroscience suggests that neural components should be considered part of this complex ecosystem.

Neural signals can affect stromal and immune compartments, while tumor and stromal cells can alter neural architecture.

This creates a feedback system.

Tumor → neural remodeling → altered signaling → immune/stromal changes → tumor progression

This bidirectional communication may help explain why some tumors develop highly supportive microenvironments that promote progression and treatment resistance.

 

Glial Cells and Cancer

Neurons are not the only neural components involved in cancer biology.

Glial cells are also receiving increasing attention.

Glial cells support and regulate neuronal function and can participate in immune and inflammatory processes.

In the tumor environment, glial cells may interact with cancer cells and immune cells.

Recent research has particularly examined astrocytes and other glial populations in brain tumors and brain metastases.

A 2026 Nature Immunology review highlighted emerging evidence that reactive astrocytes can contribute to local immunosuppression in brain tumors, potentially creating barriers to effective immunotherapy.

These findings demonstrate that cancer neuroscience extends beyond neurons.

Understanding interactions among:

neurons + glial cells + cancer cells + immune cells

could provide a more complete picture of tumor biology.

 

The Brain–Tumor Connection

Cancer neuroscience also explores communication between the brain and tumors located outside the central nervous system.

This is a particularly emerging area.

Research using neural tracing and experimental models suggests that specific brain regions can communicate with peripheral tumors through neural, neuroendocrine, and immune pathways.

A 2026 review in Oncogene described emerging evidence of functional connections between specific brain regions and peripheral solid tumors, while also noting that direct evidence for brain-driven tumor initiation remains limited.

This suggests that cancer may involve communication across distances that were previously underestimated.

Rather than considering a tumor as an isolated mass, researchers are beginning to investigate it as part of a larger physiological network.

 

Stress, Neural Signaling and Cancer Biology

Stress is another area of interest in cancer neuroscience.

The body responds to stress through complex neuroendocrine and autonomic pathways.

Stress-related signaling can influence immune function, metabolism, inflammation, and tissue physiology.

Cancer research is therefore investigating whether chronic activation of specific neural pathways can alter tumor behavior or treatment response.

However, it is important to distinguish scientific evidence from oversimplified claims.

Cancer is a complex disease caused by interacting genetic, environmental, biological, and lifestyle factors. Stress should not be presented as a simple cause of cancer.

Instead, current research focuses on understanding specific biological pathways through which neural and neuroendocrine signals may influence tumor and immune behavior.

 

Perineural Invasion: When Cancer Cells Follow Nerves

Another important connection between cancer and the nervous system is perineural invasion (PNI).

Perineural invasion occurs when cancer cells grow along or around nerves.

It is particularly relevant in several solid tumors and can be associated with aggressive disease characteristics.

Cancer cells and nerves can communicate through molecular signals that promote reciprocal growth and migration.

This creates a biological relationship in which:

• Nerves provide signals supporting tumor behavior.
• Tumor cells alter neural environments.
• Cancer cells migrate along neural structures.
• Neural remodeling can contribute to tumor progression.

Understanding PNI may therefore help researchers identify new prognostic markers and therapeutic targets.

 

Cancer Neuroscience and Metastasis

Metastasis is one of the most challenging aspects of cancer treatment.

The metastatic process involves multiple stages, including:

1. Local invasion
2. Entry into blood or lymphatic circulation
3. Survival during transport
4. Arrival at distant organs
5. Adaptation to a new microenvironment
6. Growth of metastatic lesions

Neural signals may influence several components of this process.

The nervous system can affect tumor-cell migration, immune surveillance, vascular biology, and the characteristics of distant tissues.

Researchers are also studying how metastatic cancer cells interact with nerves after reaching new organs.

These interactions may be particularly relevant in organs with highly specialized neural environments.

 

Neural Signaling and Cancer Treatment Resistance

Treatment resistance remains a major challenge in oncology.

Even when a therapy initially works, cancer cells can adapt through genetic, epigenetic, metabolic, immune, and microenvironmental mechanisms.

Cancer neuroscience adds another possible layer to this process.

Neural signals may influence:

• Cancer-cell survival
• Stress adaptation
• Immune suppression
• Metabolic changes
• Stem-like tumor states
• Microenvironmental remodeling

A 2026 review specifically identifies neural regulation of tumor progression and therapeutic resistance as an emerging area of cancer neuroscience research.

Future studies will need to determine which neural pathways are causal drivers of resistance and which are simply associated with treatment failure.

 

Can Neural Pathways Become Cancer Treatment Targets?

One of the most exciting questions is whether neural pathways can be therapeutically targeted.

Potential strategies under investigation include:

1. Neurotransmitter receptor modulation

Cancer or immune cells may express receptors for neurotransmitters.

Selective modulation of these receptors could potentially alter tumor-supportive signaling.

2. Targeting tumor innervation

Reducing or modifying abnormal nerve recruitment could potentially disrupt tumor–nerve communication.

3. Blocking neuropeptide signaling

Neuropeptides released by sensory neurons may influence tumor growth and immune responses.

4. Modulating autonomic signaling

Researchers are exploring whether selective modulation of sympathetic or parasympathetic pathways can alter tumor biology.

5. Combining neural and immune therapies

Neural pathway modulation could potentially be combined with immunotherapy to improve immune activity within tumors.

6. Neuromodulation

Some experimental approaches are investigating whether neural activity can be altered using pharmacological or device-based strategies.

However, these approaches remain under active investigation, and their clinical applicability varies considerably by cancer type and biological context.

 

Cancer Neuroscience and Precision Oncology

Precision oncology aims to match cancer treatment to the specific biological characteristics of a patient's tumor.

Traditionally, precision oncology has focused on:

• Genetic mutations
• Genomic alterations
• Biomarkers
• Protein expression
• Immune characteristics
• Molecular pathways

Cancer neuroscience could eventually expand this framework.

Future precision oncology may consider not only what mutations a tumor carries, but also:

• Which neural pathways are active?
• Which neurotransmitter receptors are expressed?
• How densely is the tumor innervated?
• Which neural subtypes are present?
• What neuroimmune interactions are occurring?
• Does neural signaling contribute to treatment resistance?

This could lead to a more comprehensive model of personalized cancer care.

 

Biomarkers in Cancer Neuroscience

An important future research area is the development of neural biomarkers.

Potential biomarkers could include:

• Neural density
• Nerve subtype
• Neurotransmitter receptor expression
• Neuropeptide levels
• Neural gene signatures
• Tumor innervation patterns
• Neuroimmune signaling profiles
• Glial-cell activity

Advanced imaging, spatial biology, single-cell analysis, and multi-omics technologies may help researchers characterize these features.

For example, spatial technologies could potentially identify where neural structures are located relative to cancer cells and immune populations.

This could provide information that conventional bulk molecular testing cannot capture.

 

Spatial Biology and Cancer Neuroscience

Spatial biology is particularly relevant to cancer neuroscience.

A tumor is spatially organized.

Cancer cells may be located near:

• Nerve fibers
• Blood vessels
• Immune cells
• Fibroblasts
• Hypoxic regions
• Metastatic niches

Understanding the spatial relationship between these components could reveal how neural signals influence cancer.

Technologies such as:

• Spatial transcriptomics
• Spatial proteomics
• Multiplex imaging
• Single-cell sequencing
• Imaging mass cytometry
• Advanced microscopy

may help researchers map the neuro-tumor-immune ecosystem.

This represents an important connection between emerging technologies and cancer neuroscience.

 

Artificial Intelligence and Cancer Neuroscience

Artificial intelligence may also become useful in this emerging field.

Cancer neuroscience can generate complex datasets involving:

• Imaging
• Neural morphology
• Spatial molecular profiles
• Single-cell data
• Receptor expression
• Clinical outcomes
• Treatment response

AI and machine learning could help identify patterns across these datasets.

Potential applications include:

• Detecting tumor innervation
• Classifying neural structures
• Predicting treatment response
• Identifying neural biomarkers
• Integrating spatial and molecular data
• Discovering neural therapeutic targets

However, AI models will require high-quality datasets and independent validation before they can be translated into reliable clinical tools.

 

Cancer Neuroscience Across Different Cancer Types

Neural regulation is being investigated across multiple cancer types.

Research has explored interactions involving:

• Pancreatic cancer
• Prostate cancer
• Breast cancer
• Colorectal cancer
• Gastric cancer
• Head and neck cancers
• Skin cancers
• Lung cancer
• Brain tumors
• Hematological malignancies

The mechanisms can differ significantly between cancers.

For example, pancreatic tumors may have extensive interactions with autonomic and sensory nerves, while brain tumors exist within an especially complex neural and immune environment.

Therefore, there is unlikely to be a single universal cancer-neuroscience mechanism.

Instead, future research will probably identify cancer-specific neurobiological signatures.

 

Cancer Neuroscience in Brain Tumors

Brain tumors provide a unique opportunity to study cancer neuroscience because malignant cells exist within the nervous system itself.

Gliomas and other central nervous system tumors interact with:

• Neurons
• Astrocytes
• Microglia
• Oligodendrocyte-lineage cells
• Brain vasculature
• Immune cells
• Neural networks

Research has demonstrated that glioma cells can interact with neuronal activity and that the surrounding neural environment can influence tumor behavior.

At the same time, immunotherapy in brain tumors faces unique challenges associated with the central nervous system and its specialized barriers.

Recent research continues to investigate how brain barriers, immune surveillance, neural activity, and tumor biology interact to influence immunotherapy responses.

 

Challenges in Cancer Neuroscience Research

Despite its promise, cancer neuroscience remains an emerging discipline.

Several challenges must be addressed.

Limited clinical validation

Many discoveries have emerged from preclinical models.

More human studies are required to determine which mechanisms have meaningful clinical relevance.

Biological complexity

The nervous system contains multiple neural subtypes with different functions.

The same neurotransmitter may produce different effects depending on the receptor and cellular context.

Tumor heterogeneity

Different tumors—and even different regions within the same tumor—may have different patterns of innervation.

Treatment specificity

Broadly disrupting neural signaling could produce unwanted neurological or systemic effects.

Therefore, therapeutic approaches must be highly selective.

Difficulty measuring neural activity

Accurately measuring neural signaling inside tumors remains technically challenging.

Translational barriers

Discovering a neural mechanism in a laboratory model does not automatically mean that it can become an effective cancer therapy.

Recent reviews emphasize that translating cancer neuroscience discoveries into clinically actionable strategies remains a major challenge.

 

The Future of Cancer Neuroscience

The future of cancer neuroscience is likely to involve increasingly sophisticated integration between oncology and neuroscience.

Several areas are particularly promising.

Neuroimmune precision medicine

Treatment strategies could eventually consider both immune and neural characteristics of a tumor.

Neural biomarkers

Neural receptor patterns and tumor innervation could become potential biomarkers for prognosis or therapy selection.

Combination therapies

Neural pathway inhibitors may eventually be evaluated alongside:

• Immunotherapy
• Targeted therapy
• Chemotherapy
• Radiation
• Anti-angiogenic treatment
• Cellular therapy

Spatial mapping of tumor innervation

Advanced spatial technologies may reveal exactly where nerves interact with cancer and immune cells.

AI-powered neuro-oncology research

AI could integrate imaging, spatial, molecular, and clinical data to identify previously hidden patterns.

Personalized neural targeting

Instead of broadly suppressing the nervous system, future treatments may selectively target tumor-associated neural pathways.

 

From Tumor Biology to Tumor Ecosystems

Cancer neuroscience contributes to a broader change in how researchers understand cancer.

Cancer is increasingly viewed not simply as a collection of malignant cells, but as a dynamic ecosystem.

Within this ecosystem:

Cancer cells communicate with immune cells.

Immune cells communicate with stromal cells.

Stromal cells influence cancer cells.

Blood vessels shape tumor behavior.

Nerves influence cancer and immune cells.

Tumors can remodel neural networks.

This interconnected system may help explain why cancer progression and treatment response are often difficult to predict using a single biological parameter.

Cancer neuroscience therefore complements—not replaces—genomics, immunology, proteomics, metabolism, pathology, and other areas of modern oncology.

 

Why Cancer Neuroscience Matters for Modern Oncology

The importance of cancer neuroscience goes beyond understanding how nerves interact with tumors.

It could potentially change how researchers think about:

• Cancer progression
• Metastasis
• Immune evasion
• Treatment resistance
• Cancer-associated pain
• Biomarker development
• Drug discovery
• Combination therapies
• Precision oncology

The field may ultimately help answer an important question:

Can cancer treatment become more effective by targeting not only cancer cells and immune pathways, but also the neural signals that help shape the tumor ecosystem?

The answer is still being investigated.

Nevertheless, the pace of research in 2026 suggests that the nervous system is becoming an increasingly important dimension of cancer biology. Recent reviews describe neural regulation as a significant but still underexplored component of tumor immunity and cancer progression.

 

Conclusion

Cancer neuroscience is emerging as an important frontier in modern oncology.

The nervous system is increasingly recognized as an active participant in the tumor microenvironment rather than simply a structure surrounding cancer.

Tumors can recruit and remodel nerves, while neural signals can influence cancer-cell behavior, immune responses, tumor progression, metastasis, and potentially treatment resistance.

The growing understanding of neuro-tumor and neuroimmune communication could open new opportunities for cancer research and therapeutic development.

Future cancer treatments may increasingly combine molecular targeting, immunotherapy, cellular therapy, precision diagnostics, and carefully selected neural interventions.

However, substantial research is still required before cancer neuroscience can be translated into routine clinical practice. Many findings remain preclinical, and the complexity of neural signaling means that therapeutic strategies will need to be highly selective and cancer-specific.

As precision oncology continues to evolve, understanding the neural dimension of cancer could provide another layer of information for predicting tumor behavior and designing individualized treatment strategies.

The intersection of neuroscience, immunology, molecular biology, and oncology may therefore become an important area of research in the next generation of cancer care.

 

Join WCOCC-2026

The World Conference on Oncology & Cancer Care (WCOCC-2026) brings together researchers, clinicians, oncologists, scientists, healthcare professionals, and experts to discuss emerging developments across cancer research and cancer care.

World Conference on Oncology & Cancer Care (WCOCC-2026)
November 19–21, 2026 | Tokyo, Japan

The conference provides an opportunity to exchange research insights, discuss emerging cancer technologies, explore innovative therapeutic approaches, and connect with the global oncology community.

Researchers and professionals interested in cancer neuroscience, neuroimmune interactions, tumor biology, precision oncology, cancer immunotherapy, and emerging cancer therapies can participate and share their work at WCOCC-2026.

Learn more about WCOCC-2026 and explore opportunities to participate in this international oncology conference.

FAQs

1. What is cancer neuroscience?

Cancer neuroscience is an emerging field that studies how the nervous system interacts with cancer cells, immune cells, and the tumor microenvironment.

2. How does the nervous system influence cancer?

Neural signals, neurotransmitters, neuropeptides, and autonomic pathways can influence tumor growth, immune responses, metastasis, and treatment response.

3. What is tumor innervation?

Tumor innervation refers to the growth or presence of nerve fibers within or around tumors. These nerves can influence cancer and immune-cell behavior.

4. What are neuro-immune interactions in cancer?

Neuro-immune interactions describe communication between neural and immune systems that can affect immune-cell activity, tumor progression, and cancer treatment response.

5. Can nerves promote tumor growth?

Yes. Research indicates that specific neural signals can support tumor growth and survival in certain cancer types, although effects vary by tumor and neural pathway.

6. Can cancer affect the nervous system?

Yes. Tumors can remodel local nerves and influence neural signaling through growth factors, inflammatory signals, and other molecular mechanisms.

7. Can cancer neuroscience improve immunotherapy?

Potentially. Researchers are studying whether targeting specific neuroimmune pathways could improve immune responses and overcome some forms of treatment resistance.

8. What is perineural invasion in cancer?

Perineural invasion occurs when cancer cells grow along or around nerves. It is associated with aggressive behavior in several types of solid tumors.

9. Can neural pathways become cancer treatment targets?

Researchers are investigating neurotransmitter receptors, tumor innervation, neuropeptide signaling, and autonomic pathways as potential therapeutic targets.

10. What is the future of cancer neuroscience?

Future research may integrate neural biomarkers, spatial biology, AI, immunotherapy, and precision medicine to better understand and treat cancer.